New hope for kids with HIV: daily pill trial seeks right dose

NCT ID NCT04375800

Recruiting now Disease control Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

Summary

This study aims to find the right dose and check the safety of a daily HIV medication combination for young children. It will include up to 84 children under 12 years old who have HIV-1 and weigh less than 45 kg. The main goal is to see how the drug moves through their bodies and to monitor for any side effects over 24 weeks.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Be Part Yoluntu Centre ( Site 0606)
RECRUITING

Paarl, Western Cape, 7626, South Africa

Contact Phone: •••-•••-••••
CEIP - Centro de Estudios en Infectología Pediátrica ( Site 1002)
RECRUITING

Cali, Valle del Cauca Department, 760042, Colombia

Contact Phone: •••-•••-••••
Ciensalud Ips S A S ( Site 1001)
RECRUITING

Barranquilla, Atlántico, 080001, Colombia

Contact Phone: •••-•••-••••
Clinica Somer ( Site 1003)
RECRUITING

Rionegro, Antioquia, 054040, Colombia

Contact Phone: •••-•••-••••
Clinical Centre for Prevention and Control of AIDS ( Site 0504)
COMPLETED

Krasnodar, Krasnodarskiy Kray, 350015, Russia
Emory Children's Center ( Site 0103)
RECRUITING

Atlanta, Georgia, 30322, United States

Contact Phone: •••-•••-••••
Empilweni Services and Research Unit ( Site 0604)
COMPLETED

Johannesburg, Gauteng, 2093, South Africa
FARMOVS PTY LTD ( Site 0601)
COMPLETED

Bloemfontein, Free State, 9301, South Africa
FGU Republican Clinical Infectious Hospital of Roszdrav ( Site 0500)
RECRUITING

Saint Petersburg, Sankt-Peterburg, 196645, Russia

Contact Phone: •••-•••-••••
Faculty of Medicine - Khon Kaen University ( Site 0903)
RECRUITING

Khon Kaen, 40002, Thailand

Contact Phone: •••-•••-••••
Family Clinic Research With UBUNTU ( Site 0605)
RECRUITING

Cape Town, Western Cape, 7505, South Africa

Contact Phone: •••-•••-••••
Hospital Infantil de Mexico Federico Gomez ( Site 0702)
ACTIVE_NOT_RECRUITING

Mexico City, Mexico City, 06720, Mexico
Infectious Clinical Hospital #2 ( Site 0501)
COMPLETED

Moscow, Moscow, 105275, Russia
Instituto Nacional de Pediatria ( Site 0701)
COMPLETED

Coyoacán, Mexico City, 04530, Mexico
King Edward Hospital ( Site 0600)
RECRUITING

Durban, KwaZulu-Natal, 4001, South Africa

Contact Phone: •••-•••-••••
Krasnoyarsk Regional Center for Prevention and Control of AIDS ( Site 0507)
COMPLETED

Krasnoyarsk, Krasnoyarsk Krai, 660049, Russia
Kuzbasskiy Center for the Prevention and Control of AIDS ( Site 0506)
RECRUITING

Kemerovo, Kemerovo Oblast, 650056, Russia

Contact Phone: •••-•••-••••
Perinatal HIV Research Unit ( Site 0602)
RECRUITING

Johannesburg, Gauteng, 1864, South Africa

Contact Phone: •••-•••-••••
Research Institute for Health Sciences ( Site 0902)
RECRUITING

Chiang Mai, 50200, Thailand

Contact Phone: •••-•••-••••
Siriraj Hospital ( Site 0901)
RECRUITING

Bangkok, Bangkok, 10700, Thailand

Contact Phone: •••-•••-••••
Tsitsikamma Clinical Research Initiative (TCRI) ( Site 0607)
COMPLETED

Plettenberg Bay, Western Cape, 6600, South Africa
Unidad de Atencion Medica e Investigacion en Salud S.C. ( Site 0700)
COMPLETED

Mérida, Yucatán, 97000, Mexico
University of Colorado at Denver ( Site 0108)
COMPLETED

Aurora, Colorado, 80045, United States
Wits Reproductive Health and HIV Institute (WRHI) ( Site 0603)
RECRUITING

Johannesburg, Gauteng, 2001, South Africa

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION